Login
Navigate Fool.com
Will SNSS beat
the market?
Community Rating: 1 Star: Ominous

5.16 -0.02 (-0.39%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.14
Previous Close $5.18
Daily Range $5.08 - $5.32
52-Week Range $3.84 - $7.49
Market Cap $310.1M
P/E Ratio -7.82
Dividend (Yield) $0.00 (0.0%)
Volume 294,269
Average Daily Volume 649,541
Current FY EPS -$0.66

How do you think SNSS
will perform against the market?

Top SNSS Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted September 12, 2011

It's been a steep decline for Sunesis as investors balk at the long wait before the VALOR phase III trial of vosaroxin in AML in 2013. I'm not ready to buy here either, as I've seen the market caps of … More

0 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals

Two clinical-stage cancer companies could provide market-beating returns for risk-tolerant investors.

Mid-Morning Market Update: Markets Drop; Family Dollar Plans To Close 370 Stores

Is Now the Time to Invest in Agios Pharmaceuticals, Inc?

Agios Pharmaceuticals reported surprisingly strong results for an early stage blood cancer drug candidate today. Should you dig deeper into this story?

Tuesday Sector Leaders: Biotechnology, Apparel Stores

3 Small Cap Biotechs Developing Novel Cancer Treatments

Three biotechs with pending clinical catalysts for their experimental cancer treatments.

3 Horrendous Health-Care Stocks This Week

Canceled clinical studies. Disappointing earnings. Double-digit declines. These three stocks had truly horrendous weeks.

Why Sunesis Pharmaceuticals, Inc. Shares Slipped

Is this meaningful or just another movement?

Why Sunesis Is Poised to Pull Back

Market-lagging returns could be written in this 1-Star.

Why Endocyte Is Poised to Pull Back

Market-lagging returns could be written in this 2-Star.

Here's What This $5 Billion Hedge Fund Has Been Buying

It can pay off to keep an eye on the big guys.

See More SNSS News...

Sector

Healthcare

Industry

Drugs

Sunesis Pharmaceuticals, Inc. (SNSS) Description

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs. Website: http://www.sunesis.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks